Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon

Overview of attention for article published in Cochrane database of systematic reviews, November 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

A GIBAC-Based Selectivity Strategy for the Design of PDE5 Inhibitors to Minimize Visual Disturbances

Preprint in Preprints.org (May 2024)

A 63-year-old Chinese female with mixed connective tissue disease who suffered from renal crisis

Article in European Journal of Inflammation (January 2024)